Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2004 2
2005 5
2006 6
2007 6
2008 8
2009 10
2010 8
2011 9
2012 4
2013 6
2014 9
2015 10
2016 6
2017 7
2018 12
2019 9
2020 22
2021 9
2022 8
2023 3
Text availability
Article attribute
Article type
Publication date

Search Results

136 results
Results by year
Filters applied: . Clear all
Page 1
The intestinal barrier in disorders of the central nervous system.
Pellegrini C, Fornai M, D'Antongiovanni V, Antonioli L, Bernardini N, Derkinderen P. Pellegrini C, et al. Among authors: fornai m. Lancet Gastroenterol Hepatol. 2023 Jan;8(1):66-80. doi: 10.1016/S2468-1253(22)00241-2. Epub 2022 Nov 2. Lancet Gastroenterol Hepatol. 2023. PMID: 36334596 Review.
Targeting SIRT1 Rescues Age- and Obesity-Induced Microvascular Dysfunction in Ex Vivo Human Vessels.
Mengozzi A, Costantino S, Paneni F, Duranti E, Nannipieri M, Mancini R, Lai M, La Rocca V, Puxeddu I, Antonioli L, Fornai M, Ghionzoli M, Georgiopoulos G, Ippolito C, Bernardini N, Ruschitzka F, Pugliese NR, Taddei S, Virdis A, Masi S. Mengozzi A, et al. Among authors: fornai m. Circ Res. 2022 Sep 2;131(6):476-491. doi: 10.1161/CIRCRESAHA.122.320888. Epub 2022 Aug 15. Circ Res. 2022. PMID: 35968712 Free PMC article.
Enteric α-synuclein impairs intestinal epithelial barrier through caspase-1-inflammasome signaling in Parkinson's disease before brain pathology.
Pellegrini C, D'Antongiovanni V, Miraglia F, Rota L, Benvenuti L, Di Salvo C, Testa G, Capsoni S, Carta G, Antonioli L, Cattaneo A, Blandizzi C, Colla E, Fornai M. Pellegrini C, et al. Among authors: fornai m. NPJ Parkinsons Dis. 2022 Jan 12;8(1):9. doi: 10.1038/s41531-021-00263-x. NPJ Parkinsons Dis. 2022. PMID: 35022395 Free PMC article.
P2X4 receptors, immunity, and sepsis.
Antonioli L, Blandizzi C, Fornai M, Pacher P, Lee HT, Haskó G. Antonioli L, et al. Among authors: fornai m. Curr Opin Pharmacol. 2019 Aug;47:65-74. doi: 10.1016/j.coph.2019.02.011. Epub 2019 Mar 25. Curr Opin Pharmacol. 2019. PMID: 30921560 Free PMC article. Review.
Editorial: IBD Management-Novel Targets and Therapeutic Perspectives.
Antonioli L, Fornai M, Romano B, Pellegrini C, Blandizzi C. Antonioli L, et al. Among authors: fornai m. Front Pharmacol. 2020 Apr 21;11:448. doi: 10.3389/fphar.2020.00448. eCollection 2020. Front Pharmacol. 2020. PMID: 32372955 Free PMC article. No abstract available.
Adenosine Signaling in the Tumor Microenvironment.
Antonioli L, Fornai M, Pellegrini C, D'Antongiovanni V, Turiello R, Morello S, Haskó G, Blandizzi C. Antonioli L, et al. Among authors: fornai m. Adv Exp Med Biol. 2021;1270:145-167. doi: 10.1007/978-3-030-47189-7_9. Adv Exp Med Biol. 2021. PMID: 33123998
Risankizumab for the treatment of moderate to severe psoriasis.
Chiricozzi A, Antonioli L, Panduri S, Fornai M, Romanelli M, Blandizzi C. Chiricozzi A, et al. Among authors: fornai m. Expert Opin Biol Ther. 2019 Jan;19(1):1-8. doi: 10.1080/14712598.2019.1551354. Epub 2018 Nov 27. Expert Opin Biol Ther. 2019. PMID: 30462554 Review.
An update of pharmacology, efficacy, and safety of vonoprazan in acid-related disorders.
Savarino V, Antonioli L, Fornai M, Marabotto E, Demarzo MG, Zingone F, Ghisa M, Barberio B, Zentilin P, Ribolsi M, Savarino E. Savarino V, et al. Among authors: fornai m. Expert Rev Gastroenterol Hepatol. 2022 May;16(5):401-410. doi: 10.1080/17474124.2021.1984878. Epub 2021 Sep 29. Expert Rev Gastroenterol Hepatol. 2022. PMID: 34550866 Review.
136 results